CeQur Announces Publication of Data Demonstrating PAQ Insulin Delivery Device Reduces Barriers to Insulin Therapy
To read the Press Release, click here.
To read the abstract, click here.
New Data Show CeQur Simple Insulin Delivery Device Improves Glycemic Control Among People with Type 2 Diabetes
To read the Press Release, click here.
CeQur Appoints Douglas Lawrence Chief Executive Officer
To read the Press Release, click here.
Diabetes Care Publishes Data Demonstrating PAQ Insulin Delivery Device Could Help People with Type 2 Diabetes Overcome Barriers to Insulin Adherence and Improve Clinical Outcomes
To read the Press Release, click here.
To read the abstract, click here.
CeQur to Present at the 32nd Annual J.P. Morgan Healthcare Conference
To read the article, click here.
CeQur Corporation Helps Lead 2013 Central Massachusetts American Diabetes Association Fundraising Effort
To read the article, click here.
Data Demonstrating Potential Benefits of Simple Insulin Delivery Device Presented at European Association for the Study of Diabetes Annual Meeting
To read the article, click here.
New Data Demonstrate Simple Insulin Delivery Device Can Significantly Reduce Barriers to Insulin Treatment Among People with Type 2 Diabetes
To read the article, click here.
CeQur Announces Positive Results from Study Evaluating Simple Insulin Delivery Device Among People with Type 2 Diabetes
To read the article, click here.
CeQur Appoints Michael Trautmann, MD Medical Director for Anti-Diabetic Peptides
To read the article, click here.
CeQur Receives CE Mark for PAQ Insulin Delivery Device
To read the article, click here.
CeQur Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People with Type 2 Diabetes
To read the article, click here.
CeQur SA Initiates Clinical Study of Simple Insulin Delivery Device for People with Type 2 Diabetes
To read the article, click here.
CeQur Establishes Wales subsidiary
To read the article, click here.
CeQur SA Closes $27 Million Series B Financing
To read the article, click here.